Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven for refractory bleeding in trauma
NCT00323570Phase 3Withdrawn
- Sponsor
- Novo Nordisk
- Start
- May 2006
- Primary completion
- Jun 2007
- Countries
- 1
01
Overview
A Phase 3 trial of coagulation factor VIIa in hemorrhage, sponsored by Novo Nordisk. Planned start May 2006; status: withdrawn.
02
Drugs
coagulation factor VIIa
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT00323570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323570.